Phage Prophylaxis of Cholera – Tufts University’s Andrew Camilli, PhD
Dr. Andrew Camilli, PhD, presented for the Levy CIMAR Monthly Science Lunch on September 30, 2021. His talk was titled: “Phage Prophylaxis of Cholera.”
October 1, 2021
Rima Mycynek
The Levy CIMAR’s own Dr. Andrew Camilli, a Professor of Molecular Biology and Microbiology at the Tufts University School of Medicine, presented on “Phage Prophylaxis of Cholera” yesterday at our first Levy CIMAR Science Lunch of the Fall Semester. You can watch a recording of this talk below.
Bacteriophages are viruses that specifically target and kill bacteria, preventing bacterial infections, and Dr. Camilli and his lab study the bacteriophages that kill V. cholerae.
Dr. Camilli is co-founder and scientific advisor to PhagePro, Inc., a Boston-based startup aiming to use bacteriophages to prevent bacterial infections. With the unmitigated rise of antibiotic resistance and the known negative consequences of gut dysbiosis caused by broad-spectrum antibiotics, bacteriophages provide a side effect-free alternative for preventing disease in clinical and community contexts.